Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Is This Myelofibrosis Drug a Blockbuster?
Motley Fool
Sat, 08/17/13 - 10:36 am
Tags:
myelofibrosis, Jakafi, Incyte
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thu, 08/15/13 - 11:48 am
Tags:
Novartis, M&A, Biomarin, Incyte
3 Sources Of Revenue For Incyte
Seeking Alpha
Thu, 06/27/13 - 12:51 am
Tags:
Incyte, Gilead, Eli Lilly, Novartis, Sanofi
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Tags:
Humira, AbbVie, Galapagos, GLPG0634, Chron's Disease, Incyte, Eli Lilly, Pfizer, rheumatoid arthritis
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire
Sun, 06/16/13 - 11:33 am
Tags:
Incyte, clinical trials, Jakafi, myelofibrosis
Lilly says arthritis pill effective in mid-stage study
Reuters
Thu, 06/13/13 - 10:45 am
Tags:
Eli Lilly, Incyte, baricitinib, rheumatoid arthritis
Incyte Jakafi outlook still positive after label revisions, says Oppenheimer
Yahoo/Fly on the Wall
Thu, 06/13/13 - 10:31 am
Tags:
Incyte, Jakafi
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
Tags:
biotech, Alkermes, Celgene, AstraZeneca, Coronado Biosciences, Dendreon, Incyte, Isis Pharmaceuticals, JNJ, Eli Lilly, Merck, Novavax, Novartis, Pfizer, Sangamo BioSciences, Pharmacyclics
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation
Yahoo/BusinessWire
Sat, 04/6/13 - 10:52 am
Tags:
Incyte, lawsuits
Incyte discloses patient treated with ruxolitinib develops PML
The Fly on the Wall
Mon, 03/18/13 - 10:56 am
Tags:
Incyte, PML, ruxolitinib, Jakafi
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Incyte Corporation
Yahoo/BusinessWire
Sun, 03/17/13 - 11:39 am
Tags:
lawsuits, Incyte
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thu, 02/28/13 - 11:35 am
Tags:
Jakafi, Incyte, myelofibrosis
Incyte Earnings: Here’s Why Investors are Happy Now
Wall St. Cheat Sheet
Fri, 02/15/13 - 11:43 am
Tags:
earnings, Incyte
Incyte Pharmaceuticals Is Primed For A Run
Seeking Alpha
Tue, 02/5/13 - 10:54 am
Tags:
Incyte, Novartis, Eli Lilly, Jakafi
JPMorgan Healthcare Conference Highlights: Incyte
Motley Fool
Tue, 01/8/13 - 10:23 am
Tags:
JPMHC 2013, Incyte
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Tags:
Eisai, Sarepta, Arena Pharmaceuticals, Amarin, Gilead, Biomarin, Onyx, Medivation, Achillion, Incyte, Cell Therapeutics, Celgene, NPS Pharmaceuticals, Aegerion, Roche, Biogen Idec, Ariad Pharmaceuticals, Alexza, Navidea, Aveo
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Tags:
Arqule, Array Biopharma, Celldex, Aveo Pharmaceutical, Curis, Exelixis, MorphoSys, Genmab, Novartis, Incyte, Seattle Genetics, YM BioSciences
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Seeking Alpha
Sat, 12/1/12 - 09:19 am
Tags:
Affymax, Genomic Health, Incyte, Infinity Pharmaceuticals, MAP Pharmaceuticals
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thu, 11/15/12 - 11:06 am
Tags:
baricitinib, Incyte, JAK inhibitors, Eli Lilly, rheumatoid arthritis
Lilly arthritis drug shows durability in study
Reuters
Tue, 11/13/12 - 05:36 pm
Tags:
Eli Lilly, baricitinib, Incyte, rheumatoid arthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.